Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by around 15 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Monopar Therapeutics

• The Trade: Monopar Therapeutics Inc. (NASDAQ:MNPR) Chief Operating Officer Andrew Cittadine bought a total of 32,508 shares at an average price of $0.79. To acquire these shares, it cost around $25,574.
• What's Happening: On June 11, Monopar and NorthStar announced amendment & extension to their collaboration.
• What Monopar Therapeutics Does: Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients.

Brookmount Explorations

• The Trade: Brookmount Explorations Inc. (OTC:BMXI) CEO Nils Ollquist acquired a total of 3,343,210 shares at an average price of $0.13. To acquire these shares, it cost around $417,901.
• What's Happening: On April 20, Brookmount Gold posted first-quarter sales of $4,540 million.
• What Brookmount Explorations Does: Brookmount Explorations is a United States based operator of producing gold properties in the Republic of Indonesia.

Nexalin Technology

• The Trade: Nexalin Technology, Inc. (NASDAQ:NXL) Chief Medical Officer David Owens acquired a total of 1,619 shares at an average price of $0.71. The insider spent around $1,150 to buy those shares.
• What's Happening: On June 20, Nexalin Technology announced a patent by the USPTO related to its deep intracranial frequency stimulation device for the treatment of Alzheimer’s and dementia.
• What Nexalin Technology Does: Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

Read More: $2M Bet On Exxon Mobil? Check Out These 3 Stocks Insiders Are Buying